94 related articles for article (PubMed ID: 15110783)
1. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages.
Llaverias G; Noé V; Peñuelas S; Vázquez-Carrera M; Sánchez RM; Laguna JC; Ciudad CJ; Alegret M
Biochem Biophys Res Commun; 2004 May; 318(1):265-74. PubMed ID: 15110783
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin decreases stearoyl-CoA desaturase gene expression in THP-1 macrophages incubated with oxidized LDL.
Martín-Fuentes P; García-Otín AL; Calvo L; Gómez-Coronado D; Civeira F; Cenarro A
Lipids; 2009 Feb; 44(2):115-23. PubMed ID: 18982375
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin suppresses inflammatory response induced by oxLDL through inhibition of ERK phosphorylation, IκBα degradation, and COX-2 expression in murine macrophages.
Shao Q; Shen LH; Hu LH; Pu J; Jing Q; He B
J Cell Biochem; 2012 Feb; 113(2):611-8. PubMed ID: 21956776
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin inhibits CD68 expression in aortic root through a GRP78-involved pathway.
Li L; Wang Y; Xu Y; Chen L; Fang Q; Yan X
Cardiovasc Drugs Ther; 2014 Dec; 28(6):523-32. PubMed ID: 25283087
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein kinase Cbeta prevents foam cell formation by reducing scavenger receptor A expression in human macrophages.
Osto E; Kouroedov A; Mocharla P; Akhmedov A; Besler C; Rohrer L; von Eckardstein A; Iliceto S; Volpe M; Lüscher TF; Cosentino F
Circulation; 2008 Nov; 118(21):2174-82. PubMed ID: 18981301
[TBL] [Abstract][Full Text] [Related]
6. Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages.
Feig JE; Shang Y; Rotllan N; Vengrenyuk Y; Wu C; Shamir R; Torra IP; Fernandez-Hernando C; Fisher EA; Garabedian MJ
PLoS One; 2011; 6(12):e28534. PubMed ID: 22163030
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway.
Hu LH; Zhang T; Shao Q; Li DD; Jin SX; Nie P; Yi J; He B; Shen LH
Mol Cell Biochem; 2012 Dec; 371(1-2):105-13. PubMed ID: 22890916
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
Moon JH; Kang SB; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Metabolism; 2011 Jul; 60(7):930-40. PubMed ID: 20951395
[TBL] [Abstract][Full Text] [Related]
9. The effect of oxLDL on aortic valve calcification via the Wnt/ β-catenin signaling pathway: an important molecular mechanism.
Gao X; Zhang L; Gu G; Wu PH; Jin S; Hu W; Zhan C; Li J; Li Y
J Heart Valve Dis; 2015 Mar; 24(2):190-6. PubMed ID: 26204684
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes.
Fuhrman B; Koren L; Volkova N; Keidar S; Hayek T; Aviram M
Atherosclerosis; 2002 Sep; 164(1):179-85. PubMed ID: 12119208
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
[TBL] [Abstract][Full Text] [Related]
12. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
[TBL] [Abstract][Full Text] [Related]
13. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions.
Schlittenhardt D; Schober A; Strelau J; Bonaterra GA; Schmiedt W; Unsicker K; Metz J; Kinscherf R
Cell Tissue Res; 2004 Nov; 318(2):325-33. PubMed ID: 15459768
[TBL] [Abstract][Full Text] [Related]
14. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice.
Trogan E; Choudhury RP; Dansky HM; Rong JX; Breslow JL; Fisher EA
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2234-9. PubMed ID: 11842210
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of atorvastatin against oxidized LDL-induced downregulation of KLF expression in EA.hy926 cells.
Gao Y; Liu XF; Lu XC; Ma C; Cao J; Fan L
Int J Mol Med; 2012 Aug; 30(2):330-6. PubMed ID: 22614632
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic effects of probucol are associated with downregulation of Daxx expression in THP-1 macrophage.
Su B; Yang YB; Tuo QH; Zhu BY; Lei XY; Yin W; Liao DF
Cardiovasc Drugs Ther; 2007 Feb; 21(1):37-45. PubMed ID: 17370120
[TBL] [Abstract][Full Text] [Related]
17. Berberine combined with atorvastatin downregulates LOX‑1 expression through the ET‑1 receptor in monocyte/macrophages.
Chi L; Peng L; Hu X; Pan N; Zhang Y
Int J Mol Med; 2014 Jul; 34(1):283-90. PubMed ID: 24756769
[TBL] [Abstract][Full Text] [Related]
18. Effects of lycopene on the induction of foam cell formation by modified LDL.
Napolitano M; De Pascale C; Wheeler-Jones C; Botham KM; Bravo E
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1820-7. PubMed ID: 17911344
[TBL] [Abstract][Full Text] [Related]
19. Effects of oxidized low- and high-density lipoproteins on gene expression of human macrophages.
Levula M; Jaakkola O; Luomala M; Nikkari ST; Lehtimäki T
Scand J Clin Lab Invest; 2006; 66(6):497-508. PubMed ID: 17000557
[TBL] [Abstract][Full Text] [Related]
20. Effect of atorvastatin on ApoE and ApoC-I synthesis and secretion by THP-1 macrophages.
Castilho LN; Chamberland A; Boulet L; Davignon J; Cohn JS; Bernier L
J Cardiovasc Pharmacol; 2003 Aug; 42(2):251-7. PubMed ID: 12883330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
